Spyre Therapeutics Inc

NEW
FRA:3920 (USA)  
€ 87.5 +1 (+1.16%) Jul 24
At Loss
P/B:
15.64
Market Cap:
€ 7.80B ($ 8.89B)
Enterprise V:
€ 7.28B ($ 8.30B)
Volume:
208.00
Avg Vol (2M):
119.00
Trade In:

Spyre Therapeutics Inc Operating Data

Spyre Therapeutics Inc Competitors' Latest Operating Data

Operating data not available.

Spyre Therapeutics Inc (FRA:3920) Operating Data Charts